NYSE:BLCOMedical Equipment
Is Bausch + Lomb’s Glaucoma Focus Reframing Its Innovation Story for Investors (BLCO)?
Bausch + Lomb recently held a special call to discuss two glaucoma assets and deeper insights into its differentiated product pipeline, following the unveiling of this pipeline in November 2025.
Alongside this, CEO and Chairman Brenton L. Saunders’ presentation at the Longwood Healthcare Leaders Miami conference highlighted management’s effort to spotlight innovation and future product opportunities to a healthcare-focused investor audience.
We will now explore how the focused glaucoma call...